Pharmacologic targeting of the dopamine D2 receptor impacts the efficacy of immune checkpoint blockade in melanoma.
药物靶向多巴胺 D2 受体可影响黑色素瘤免疫检查点阻断疗法的疗效。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-014080
Gregory Mark, Hackett Justin B, Hughes Savannah, Muñiz Maria C, Ayoub Samantha, Boerner Alexander, Alrabaa Habib, Taylor Lucien, Rivera Brianna, Holland Hanna, Dyson Greg, Daveluy Steven, Gibson Heather